RxDoctor Payments DataLook up a doctor →

GLASSIA: payments to doctors

Payments that named GLASSIA as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$2.2M
Providers
9,467
Transactions
44,610
Average per transaction
$50

The per-transaction average — $50 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 9,467 providers the average total is $235, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
Takeda Pharmaceuticals U.S.A., Inc.$1,973,64488.7%
Shire North American Group Inc$252,25211.3%
← All drugs & devices